By Mike Stobbe
A month after federal officials recommended new versions of COVID-19 vaccines, 7% of U.S. adults and 2% of children have gotten a shot.
One expert called the rates “abysmal.”
The numbers, presented Thursday at a meeting held by the Centers for Disease Control and Prevention, come from a national survey of thousands of Americans, conducted two weeks ago.
The data also indicated that nearly 40% of adults said they probably or definitely will not get the shot. A similar percentage of parents said they did not plan to vaccinate their children.
In the late summer, government health officials made the nation's COVID-19 vaccination campaign more like the annual flu campaign.
Officials approved updated shots that have a single target, an omicron descendant named XBB.1.5. They replaced vaccines that targeted the original coronavirus strain and a much earlier omicron version. Last month, the CDC recommended the new shots for everyone 6 months and older.
The government also transitioned to a commercialized system that relied on the health-care industry — not the government — to handle the distribution of the shots. Many people who immediately went for shots said pharmacies or doctors didn't have them.
Americans have been urged to get different iterations of the vaccines for more than 2/12 years. This year, COVID-19 deaths and hospitalizations fell to lower levels than seen in the previous three years.
Cases remain low compared with the pandemic's early months. Even so, health officials say about 18,000 hospitalization and 1,200 deaths are still being reported each week.
One expert at the meeting, Dr. Camille Kotton of Harvard Medical School, called the numbers “abysmal” and said part of the problem may be patient confusion. She urged stepped-up public education efforts.
Dr. David Kimberlin, of the University of Alabama at Birmingham, also expressed dismay.
“The recommendations are not being heard," he said.
These are the headlines you Need 2 Know.
Relief for migraine suffers may, at long last, be imminent. With the FDA approving Eli Lilly's Emgality drug, Christi Shaw, president of Lilly Bio-Medicines, expounded on the drug's potential efficacy. The company has said it will offer the treatment to chronic migraine suffers with commercial insurance for free for a year.
These are the headlines you Need 2 Know.
These are the headlines you Need 2 Know.
Facebook announced its newest VR headset that will ship next year. "Oculus Quest" offers users the same virtual experience, but now users are able to move more freely while wearing the headset. Andrew Bosworth, VP of VR/AR at Facebook, said this is the next step in better connecting people around the world.
North Carolina is facing a new crisis a week after Hurricane Florence made landfall. Not only have millions of farm animals drowned in the initial floods. Now, flooded waste lagoons are contaminating the drinking water, explained Zoë Schlanger, environment reporter for Quartz.
Tilray, the Canadian cannabis company swiftly becoming one of the most talked-about stocks of the year, was up as much as 50 percent on Wednesday morning, leading a continued bull run in pot stocks and putting its market cap above established companies like Macy's and Viacom.
Elon Musk and SpaceX announced the company's first private passenger, Japanese billionaire Yusaku Maezawa. Shannon Stirone, freelance science journalist, said that this is the first step to Musk's ultimate goal ー transporting people to Mars.
Insurers should expect losses in the tens of billions of dollars due to Hurricane Florence's rain, which will linger for days because of the system's slow movement, said Mark Watson, CEO of Argo Group.
Natural disasters, hurricanes especially, were once opportunities for administrations to flex their leadership and empathy muscles. When they failed (see: Bush, Katrina), the results were politically devastating. When they succeeded (see: Christie, Sandy), they launched runs for office. Those days appear to be over.
